Skip to content

Effect of Water Intake and Water Restriction on Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease

Effect of Water Intake and Water Restriction on Total Kidney Volume in Autosomal Dominant Polycystic Kidney: The HYDRA Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02776241
Enrollment
40
Registered
2016-05-18
Start date
2015-09-30
Completion date
2017-01-31
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ADPKD

Keywords

ADPKD, total kidney volume, kidney disease

Brief summary

The objective of this study is to measure the influence of both short term water restriction and high water intake on total kidney volume, measured by Magnetic Resonance Imaging (MRI) scan in Autosomal Dominant Polycystic Kidney Disease (ADPKD) patients.

Detailed description

Patients will be randomized to either water restriction for 3 hours or high water intake (20 ml/kg) for 1 hour. Before intervention and after intervention patients will have an MRI scan of the kidneys to measure the total kidney volume (TKV) (differentiated in cortex, medulla and cyst volume). The objective is to identify whether water restriction or high water load will change the TKV. Secondly investigators will analyze different biomarkers (aldosterone, renin, vasopressin/copeptin, urine- and blood-osmolarity) before and after the intervention.

Interventions

OTHERwater

Sponsors

Aarhus University Hospital
CollaboratorOTHER
Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ADPKD * CKD stage 1-3

Exclusion criteria

* Patients treated with diuretics * Pregnancy * Change in antihypertensive treatment \< 1 month * Any condition contraindicating MR scan

Design outcomes

Primary

MeasureTime frame
Change in total kidney volumeBaseline and 3 hours

Secondary

MeasureTime frame
Change in total cyst volumeBaseline and 3 hours
Change in plasma reninBaseline and 3 hours
Change in plasma aldosteroneBaseline and 3 hours
Change in plasma copeptinBaseline and 3 hours

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026